Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Bonnie H Anderson. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Bonnie H Anderson har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:BRKR / Bruker Corporation | Director | 13 327 |
US:VCYT / Veracyte, Inc. | Director | 41 377 |
US:CSTL / Castle Biosciences, Inc. | Director | 21 723 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Bonnie H Anderson. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp CSTL / Castle Biosciences, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CSTL / Castle Biosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CSTL / Castle Biosciences, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp VCYT / Veracyte, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CSTL / Castle Biosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CSTL / Castle Biosciences, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Bonnie H Anderson som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-19 |
|
4 | BRKR |
BRUKER CORP
Common Stock |
A - Award | 3 298 | 13 327 | 32,88 | ||||
2024-01-09 |
|
4 | BRKR |
BRUKER CORP
Common Stock |
A - Award | 2 377 | 10 029 | 31,06 | ||||
2023-06-06 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −1 304 | 41 377 | −3,06 | 26,72 | −34 843 | 1 105 593 | |
2023-04-18 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −34 000 | 42 681 | −44,34 | 22,04 | −749 357 | 940 685 |
2023-04-18 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 34 000 | 76 681 | 79,66 | 5,61 | 190 740 | 430 180 |
2023-03-16 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −34 000 | 53 967 | −38,65 | 22,76 | −773 888 | 1 228 364 |
2023-03-16 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 34 000 | 87 967 | 63,00 | 5,61 | 190 740 | 493 495 |
2023-03-03 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −8 994 | 53 967 | −14,29 | 24,10 | −216 755 | 1 300 605 | |
2023-02-22 | 3/A | BRKR |
BRUKER CORP
Common Stock |
41 | ||||||||
2023-01-18 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −4 494 | 62 961 | −6,66 | 26,64 | −119 726 | 1 677 369 |
2023-01-18 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −29 506 | 67 455 | −30,43 | 26,30 | −776 111 | 1 774 303 |
2023-01-18 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 34 000 | 96 961 | 54,00 | 5,61 | 190 740 | 543 951 |
2023-01-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −63 247 | 62 961 | −50,11 | 25,13 | −1 589 195 | 1 582 008 |
2023-01-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 63 247 | 126 208 | 100,45 | 14,34 | 906 962 | 1 809 823 |
2023-01-09 |
|
4 | BRKR |
BRUKER CORP
Common Stock |
A - Award | 1 970 | 7 652 | 34,67 | ||||
2022-12-06 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −2 042 | 62 961 | −3,14 | 29,14 | −59 504 | 1 834 684 | |
2022-12-05 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −45 460 | 65 003 | −41,15 | 28,60 | −1 300 301 | 1 859 294 |
2022-12-05 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −34 540 | 110 463 | −23,82 | 27,81 | −960 447 | 3 071 623 |
2022-12-05 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 30 000 | 145 003 | 26,09 | 5,61 | 168 300 | 813 467 |
2022-12-05 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 50 000 | 115 003 | 76,92 | 14,34 | 717 000 | 1 649 143 |
2022-10-17 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 9 244 | 76 091 | 13,83 | 9,05 | 83 658 | 688 624 | |
2022-10-17 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 1 844 | 66 847 | 2,84 | 8,86 | 16 338 | 592 264 | |
2022-09-07 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −2 042 | 65 003 | −3,05 | 19,18 | −39 166 | 1 246 758 | |
2022-08-09 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | −5 769 | 112 426 | −4,88 | 27,82 | −160 497 | 3 127 759 | |
2022-08-09 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | −39 231 | 118 195 | −24,92 | 27,24 | −1 068 578 | 3 219 407 | |
2022-08-09 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | −76 917 | 157 426 | −32,82 | 27,71 | −2 131 370 | 4 362 274 | |
2022-06-06 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −2 042 | 67 045 | −2,96 | 18,23 | −37 226 | 1 222 230 | |
2022-05-03 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −736 | 85 952 | −0,85 | 20,47 | −15 066 | 1 759 437 | |
2022-03-07 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 32 195 | 32 195 | |||||
2022-03-07 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
A - Award | 17 667 | 86 688 | 25,60 | ||||
2022-03-04 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −4 521 | 69 021 | −6,15 | 27,84 | −125 865 | 1 921 545 | |
2022-01-06 |
|
4 | BRKR |
BRUKER CORP
Common Stock |
A - Award | 1 841 | 5 682 | 47,93 | ||||
2021-12-10 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −11 286 | 1 844 | −85,96 | ||||
2021-12-10 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 11 286 | 73 542 | 18,13 | 8,86 | 99 994 | 651 582 | |
2021-12-06 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −2 288 | 62 256 | −3,54 | 39,22 | −89 735 | 2 441 680 | |
2021-09-21 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −2 600 | 217 478 | −1,18 | 50,18 | −130 478 | 10 913 851 |
2021-09-14 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −1 900 | 220 078 | −0,86 | 50,03 | −95 050 | 11 009 644 |
2021-09-07 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −2 288 | 64 544 | −3,42 | 52,97 | −121 195 | 3 418 896 | |
2021-06-04 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −2 288 | 189 725 | −1,19 | 36,07 | −82 528 | 6 843 381 | |
2021-05-19 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −14 065 | 166 117 | −7,81 | ||||
2021-05-19 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 14 065 | 192 013 | 7,90 | 5,61 | 78 905 | 1 077 193 | |
2021-03-04 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −6 320 | 177 948 | −3,43 | 62,15 | −392 788 | 11 059 468 | |
2021-03-02 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
2021-03-02 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
A - Award | 20 000 | 184 268 | 12,18 | ||||
2021-02-26 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −39 488 | 164 268 | −19,38 | 62,30 | −2 460 102 | 10 233 896 | |
2021-01-15 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −18 541 | 180 182 | −9,33 | |||
2021-01-15 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −12 177 | 203 756 | −5,64 | 51,26 | −624 180 | 10 444 308 |
2021-01-15 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −6 364 | 215 933 | −2,86 | 50,64 | −322 283 | 10 935 171 |
2021-01-15 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 18 541 | 222 297 | 9,10 | 5,61 | 104 015 | 1 247 086 |
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −20 354 | 198 723 | −9,29 | |||
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −400 | 203 756 | −0,20 | 51,20 | −20 480 | 10 432 205 |
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −15 568 | 204 156 | −7,09 | 50,29 | −782 982 | 10 267 883 |
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −4 386 | 219 724 | −1,96 | 49,77 | −218 311 | 10 936 652 |
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 354 | 224 110 | 9,99 | 5,61 | 114 186 | 1 257 257 |
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −5 923 | 219 077 | −2,63 | |||
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −65 182 | 13 130 | −83,23 | |||
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −11 497 | 203 756 | −5,34 | 51,56 | −592 751 | 10 505 048 |
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −34 257 | 215 253 | −13,73 | 50,90 | −1 743 839 | 10 957 368 |
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −25 351 | 249 510 | −9,22 | 49,81 | −1 262 713 | 12 427 893 |
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 5 923 | 274 861 | 2,20 | 5,61 | 33 228 | 1 541 970 |
2021-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 65 182 | 268 938 | 31,99 | 8,86 | 577 513 | 2 382 791 |
2021-01-07 |
|
4 | BRKR |
BRUKER CORP
Common Stock |
A - Award | 2 302 | 3 841 | 149,58 | ||||
2020-12-30 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −25 000 | 0 | −100,00 | ||||
2020-12-30 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −6 313 | 0 | −100,00 | ||||
2020-12-30 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 25 000 | 203 756 | 13,99 | 4,00 | 100 000 | 815 024 | |
2020-12-30 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 6 313 | 178 756 | 3,66 | 2,68 | 16 919 | 479 066 | |
2020-12-04 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −1 976 | 172 443 | −1,13 | 55,08 | −108 838 | 9 498 160 | |
2020-11-12 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −20 000 | 78 312 | −20,34 | |||
2020-11-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
G - Gift | 22 906 | 47 906 | 91,62 | ||||
2020-11-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
G - Gift | 22 906 | 47 906 | 91,62 | ||||
2020-11-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
G - Gift | −22 906 | 174 419 | −11,61 | ||||
2020-11-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
G - Gift | −22 906 | 174 419 | −11,61 | ||||
2020-11-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | −3 419 | 220 231 | −1,53 | 43,61 | −149 117 | 9 605 177 |
2020-11-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | −8 218 | 223 650 | −3,54 | 43,02 | −353 555 | 9 621 870 |
2020-11-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | −4 370 | 231 868 | −1,85 | 42,01 | −183 582 | 9 740 682 |
2020-11-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | −3 993 | 236 238 | −1,66 | 40,99 | −163 675 | 9 683 537 |
2020-11-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 000 | 240 231 | 9,08 | 8,86 | 177 200 | 2 128 447 |
2020-10-09 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −50 000 | 98 312 | −33,71 | |||
2020-10-09 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −50 000 | 220 231 | −18,50 | 38,00 | −1 900 000 | 8 368 778 |
2020-10-09 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 50 000 | 270 231 | 22,70 | 8,86 | 443 000 | 2 394 247 |
2020-09-14 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −20 000 | 148 312 | −11,88 | |||
2020-09-14 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −6 607 | 220 231 | −2,91 | 31,47 | −207 926 | 6 930 802 |
2020-09-14 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −13 393 | 226 838 | −5,58 | 30,61 | −409 934 | 6 943 080 |
2020-09-14 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 000 | 240 231 | 9,08 | 8,86 | 177 200 | 2 128 447 |
2020-09-08 | 3 | BRKR |
BRUKER CORP
No securities are beneficially owned. |
0 | ||||||||
2020-09-08 |
|
4 | BRKR |
BRUKER CORP
Common Stock |
A - Award | 1 539 | 1 539 | |||||
2020-09-04 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −1 976 | 220 231 | −0,89 | 34,16 | −67 500 | 7 523 091 | |
2020-08-12 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −20 000 | 168 312 | −10,62 | |||
2020-08-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | −20 000 | 222 207 | −8,26 | 32,22 | −644 478 | 7 160 376 |
2020-08-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 000 | 242 207 | 9,00 | 8,86 | 177 200 | 2 145 954 |
2020-08-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
G - Gift | 25 000 | 25 000 | |||||
2020-08-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
G - Gift | 25 000 | 25 000 | |||||
2020-08-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
G - Gift | −25 000 | 222 207 | −10,11 | ||||
2020-08-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
G - Gift | −25 000 | 222 207 | −10,11 | ||||
2020-07-31 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −11 365 | 188 312 | −5,69 | |||
2020-07-31 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −11 365 | 272 207 | −4,01 | 32,24 | −366 399 | 8 775 736 |
2020-07-31 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 11 365 | 283 572 | 4,18 | 8,86 | 100 694 | 2 512 448 |
2020-07-28 |
|
4 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
S - Sale | X | −9 | 21 723 | −0,04 | 45,06 | −406 | 978 838 |
2020-07-28 |
|
4 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 763 | 21 732 | −7,50 | 44,00 | −77 572 | 956 208 |
2020-07-28 |
|
4 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 228 | 23 495 | −4,97 | 42,90 | −52 681 | 1 007 936 |
2020-07-28 |
|
4/A | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
S - Sale | X | −9 | 21 723 | −0,04 | 45,06 | −406 | 978 838 |
2020-07-28 |
|
4/A | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 763 | 21 732 | −7,50 | 44,00 | −77 572 | 956 208 |
2020-07-28 |
|
4/A | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 228 | 23 495 | −4,97 | 42,90 | −52 681 | 1 007 936 |
2020-07-27 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −3 280 | 199 677 | −1,62 | ||||
2020-07-27 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −3 280 | 272 207 | −1,19 | 32,04 | −105 106 | 8 722 764 |
2020-07-27 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 3 280 | 275 487 | 1,20 | 8,86 | 29 061 | 2 440 815 |
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −100 | 202 957 | −0,05 | |||
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −100 | 272 207 | −0,04 | 32,00 | −3 200 | 8 710 624 |
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 100 | 272 307 | 0,04 | 8,86 | 886 | 2 412 640 |
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −3 447 | 203 057 | −1,67 | |||
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −3 447 | 272 207 | −1,25 | 32,09 | −110 614 | 8 735 068 |
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 3 447 | 275 654 | 1,27 | 8,86 | 30 540 | 2 442 294 |
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −18 496 | 206 504 | −8,22 | |||
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −1 853 | 25 000 | −6,90 | |||
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −20 349 | 272 207 | −6,96 | 32,04 | −651 911 | 8 720 560 |
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 18 496 | 292 556 | 6,75 | 8,86 | 163 875 | 2 592 046 |
2020-07-27 |
|
4/A | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 1 853 | 274 060 | 0,68 | 4,00 | 7 412 | 1 096 240 |
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −100 | 104 519 | −0,10 | |||
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −100 | 272 207 | −0,04 | 32,00 | −3 200 | 8 710 624 |
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 100 | 272 307 | 0,04 | 8,86 | 886 | 2 412 640 |
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −3 447 | 104 619 | −3,19 | |||
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −3 447 | 272 207 | −1,25 | 32,09 | −110 614 | 8 735 068 |
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 3 447 | 275 654 | 1,27 | 8,86 | 30 540 | 2 442 294 |
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −18 496 | 108 066 | −14,61 | |||
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −1 853 | 25 000 | −6,90 | |||
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −20 349 | 272 207 | −6,96 | 32,04 | −651 911 | 8 720 560 |
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 18 496 | 292 556 | 6,75 | 8,86 | 163 875 | 2 592 046 |
2020-07-22 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 1 853 | 274 060 | 0,68 | 4,00 | 7 412 | 1 096 240 |
2020-06-17 |
|
4 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
S - Sale | X | −6 000 | 24 723 | −19,53 | 40,00 | −240 000 | 988 920 |
2020-06-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −20 000 | 26 853 | −42,69 | |||
2020-06-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −20 000 | 272 207 | −6,84 | 26,56 | −531 260 | 7 230 635 |
2020-06-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 000 | 292 207 | 7,35 | 4,00 | 80 000 | 1 168 828 |
2020-06-08 |
|
4 | CSTL |
CASTLE BIOSCIENCES INC
Stock option (right to buy) |
A - Award | 8 000 | 8 000 | |||||
2020-06-04 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −1 976 | 272 207 | −0,72 | 26,01 | −51 396 | 7 080 104 | |
2020-05-14 |
|
4 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
S - Sale | X | −4 000 | 30 723 | −11,52 | 35,00 | −140 000 | 1 075 305 |
2020-05-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −20 000 | 46 853 | −29,92 | 4,00 | −80 000 | 187 412 | |
2020-05-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 10 920 | 10 920 | |||||
2020-05-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −200 | 274 183 | −0,07 | 27,10 | −5 420 | 7 430 359 |
2020-05-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −19 800 | 274 383 | −6,73 | 26,66 | −527 914 | 7 315 682 |
2020-05-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 000 | 294 183 | 7,29 | 4,00 | 80 000 | 1 176 732 |
2020-05-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
A - Award | 1 870 | 274 183 | 0,69 | ||||
2020-05-04 |
|
4 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
S - Sale | X | −462 | 34 723 | −1,31 | 31,10 | −14 368 | 1 079 885 |
2020-05-04 |
|
4 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
S - Sale | X | −2 538 | 35 185 | −6,73 | 30,09 | −76 368 | 1 058 717 |
2020-03-23 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −16 000 | 6 313 | −71,71 | ||||
2020-03-23 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 16 000 | 272 313 | 6,24 | 2,68 | 42 880 | 729 799 | |
2020-03-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −20 000 | 30 241 | −39,81 | |||
2020-03-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −20 000 | 256 313 | −7,24 | 25,18 | −503 520 | 6 452 936 |
2020-03-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 000 | 276 313 | 7,80 | 4,00 | 80 000 | 1 105 252 |
2020-03-03 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −4 937 | 256 313 | −1,89 | ||||
2020-03-03 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 192 500 | 192 500 | |||||
2020-03-03 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
A - Award | 33 000 | 261 250 | 14,46 | ||||
2020-02-26 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −39 488 | 228 250 | −14,75 | ||||
2020-02-26 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
A - Award | 150 000 | 267 738 | 127,40 | ||||
2020-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −20 000 | 50 241 | −28,47 | |||
2020-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −20 000 | 117 738 | −14,52 | 28,86 | −577 276 | 3 398 366 |
2020-01-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 000 | 137 738 | 16,99 | 4,00 | 80 000 | 550 952 |
2019-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −15 000 | 22 313 | −40,20 | ||||
2019-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −20 000 | 70 241 | −22,16 | |||
2019-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 15 000 | 117 738 | 14,60 | 2,68 | 40 200 | 315 538 | |
2019-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −20 000 | 102 738 | −16,29 | 28,96 | −579 248 | 2 975 539 |
2019-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 000 | 122 738 | 19,47 | 4,00 | 80 000 | 490 952 |
2019-12-04 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −988 | 102 738 | −0,95 | 27,19 | −26 864 | 2 793 446 | |
2019-11-18 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −20 000 | 90 241 | −18,14 | |||
2019-11-18 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −20 000 | 103 726 | −16,16 | 25,06 | −501 124 | 2 598 979 |
2019-11-18 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 000 | 123 726 | 19,28 | 4,00 | 80 000 | 494 904 |
2019-10-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −2 259 | 110 241 | −2,01 | |||
2019-10-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −5 041 | 0 | −100,00 | |||
2019-10-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −8 000 | 103 726 | −7,16 | 24,50 | −196 005 | 2 541 349 |
2019-10-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 2 259 | 111 726 | 2,06 | 4,00 | 9 036 | 446 904 |
2019-10-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 5 041 | 109 467 | 4,83 | 2,68 | 13 510 | 293 372 |
2019-09-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −4 815 | 104 426 | −4,41 | 25,04 | −120 560 | 2 614 670 |
2019-09-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −1 787 | 109 241 | −1,61 | 24,08 | −43 026 | 2 630 217 |
2019-09-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −1 398 | 111 028 | −1,24 | 23,27 | −32 528 | 2 583 322 |
2019-09-05 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −988 | 112 426 | −0,87 | 25,09 | −24 789 | 2 820 768 | |
2019-08-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −1 459 | 5 041 | −22,45 | |||
2019-08-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −8 000 | 113 414 | −6,59 | 25,28 | −202 237 | 2 867 061 |
2019-08-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 1 459 | 121 414 | 1,22 | 2,68 | 3 910 | 325 390 |
2019-07-31 |
|
4 | CSTL |
CASTLE BIOSCIENCES INC
Series F Preferred Stock |
C - Conversion | −17 180 | 0 | −100,00 | ||||
2019-07-31 |
|
4 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
C - Conversion | 14 093 | 14 093 | |||||
2019-07-24 | 3 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
47 260 | ||||||||
2019-07-24 | 3 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
47 260 | ||||||||
2019-07-24 | 3 | CSTL |
CASTLE BIOSCIENCES INC
Common Stock |
47 260 | ||||||||
2019-07-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −8 000 | 6 500 | −55,17 | |||
2019-07-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −147 | 119 955 | −0,12 | 29,41 | −4 324 | 3 528 212 |
2019-07-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −7 853 | 120 102 | −6,14 | 28,78 | −225 990 | 3 456 247 |
2019-07-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 8 000 | 127 955 | 6,67 | 2,68 | 21 440 | 342 919 |
2019-06-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −8 000 | 14 500 | −35,56 | |||
2019-06-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −8 000 | 119 955 | −6,25 | 26,33 | −210 635 | 3 158 343 |
2019-06-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 8 000 | 127 955 | 6,67 | 2,68 | 21 440 | 342 919 |
2019-06-05 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −18 125 | 0 | −100,00 | ||||
2019-06-05 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −7 526 | 0 | −100,00 | ||||
2019-06-05 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 18 125 | 119 955 | 17,80 | 2,36 | 42 775 | 283 094 | |
2019-06-05 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 7 526 | 101 830 | 7,98 | 2,36 | 17 761 | 240 319 | |
2019-06-05 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −988 | 94 304 | −1,04 | ||||
2019-05-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −8 000 | 22 500 | −26,23 | |||
2019-05-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | −2 340 | 95 292 | −2,40 | 23,52 | −55 045 | 2 241 611 | |
2019-05-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | −5 660 | 97 632 | −5,48 | 22,77 | −128 903 | 2 223 510 | |
2019-05-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 8 000 | 103 292 | 8,40 | 2,68 | 21 440 | 276 823 |
2019-04-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −8 000 | 30 500 | −20,78 | |||
2019-04-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −8 000 | 95 292 | −7,75 | 25,39 | −203 084 | 2 419 035 |
2019-04-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 8 000 | 103 292 | 8,40 | 2,68 | 21 440 | 276 823 |
2019-03-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
G - Gift | −7 300 | 95 292 | −7,12 | ||||
2019-03-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −8 000 | 38 500 | −17,20 | |||
2019-03-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −8 000 | 102 592 | −7,23 | 19,97 | −159 746 | 2 048 578 |
2019-03-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 8 000 | 110 592 | 7,80 | 2,68 | 21 440 | 296 387 |
2019-03-04 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
F - Taxes | −3 949 | 102 592 | −3,71 | ||||
2019-02-28 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 225 000 | 225 000 | |||||
2019-02-28 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
A - Award | 30 000 | 106 541 | 39,19 | ||||
2019-02-28 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −20 000 | 46 500 | −30,08 | |||
2019-02-28 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −4 700 | 76 541 | −5,79 | 21,58 | −101 406 | 1 651 426 |
2019-02-28 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −15 300 | 81 241 | −15,85 | 20,74 | −317 324 | 1 684 946 |
2019-02-28 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 20 000 | 96 541 | 26,13 | 2,68 | 53 600 | 258 730 |
2019-02-12 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −8 000 | 66 500 | −10,74 | |||
2019-02-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −8 000 | 76 541 | −9,46 | 18,17 | −145 364 | 1 390 788 |
2019-02-12 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 8 000 | 84 541 | 10,45 | 2,68 | 21 440 | 226 570 |
2019-01-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −8 000 | 74 500 | −9,70 | |||
2019-01-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −1 728 | 76 541 | −2,21 | 16,14 | −27 893 | 1 235 510 |
2019-01-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −6 272 | 78 269 | −7,42 | 15,52 | −97 355 | 1 214 907 |
2019-01-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 8 000 | 84 541 | 10,45 | 2,68 | 21 440 | 226 570 |
2019-01-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −17 500 | 82 500 | −17,50 | |||
2019-01-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −17 500 | 76 541 | −18,61 | 15,12 | −264 649 | 1 157 514 |
2019-01-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 17 500 | 94 041 | 22,86 | 2,68 | 46 900 | 252 030 |
2018-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −24 000 | 7 526 | −76,13 | ||||
2018-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 24 000 | 76 541 | 45,68 | 2,36 | 56 640 | 180 637 | |
2018-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −1 305 | 100 000 | −1,29 | |||
2018-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −6 695 | 0 | −100,00 | |||
2018-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −8 000 | 52 541 | −13,21 | 12,13 | −97 077 | 637 564 |
2018-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 1 305 | 60 541 | 2,20 | 2,68 | 3 497 | 162 250 |
2018-12-11 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 6 695 | 59 236 | 12,74 | 2,36 | 15 800 | 139 797 |
2018-11-13 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −23 305 | 6 695 | −77,68 | |||
2018-11-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −1 691 | 52 541 | −3,12 | 13,82 | −23 366 | 725 991 |
2018-11-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −21 614 | 54 232 | −28,50 | 13,39 | −289 420 | 726 188 |
2018-11-13 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 23 305 | 75 846 | 44,36 | 2,36 | 55 000 | 178 997 |
2018-08-28 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −6 000 | 101 305 | −5,59 | |||
2018-08-28 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −6 000 | 52 541 | −10,25 | 12,00 | −71 971 | 630 240 |
2018-08-28 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 6 000 | 58 541 | 11,42 | 2,68 | 16 080 | 156 890 |
2018-08-03 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −14 950 | 107 305 | −12,23 | |||
2018-08-03 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −14 950 | 52 541 | −22,15 | 11,50 | −171 925 | 604 222 |
2018-08-03 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 14 950 | 67 491 | 28,45 | 2,68 | 40 066 | 180 876 |
2018-07-26 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −50 | 122 255 | −0,04 | |||
2018-07-26 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −50 | 52 541 | −0,10 | 11,50 | −575 | 604 222 |
2018-07-26 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 50 | 52 591 | 0,10 | 2,68 | 134 | 140 944 |
2018-07-24 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −6 000 | 122 305 | −4,68 | |||
2018-07-24 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −6 000 | 52 541 | −10,25 | 10,20 | −61 175 | 535 698 |
2018-07-24 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 6 000 | 58 541 | 11,42 | 2,68 | 16 080 | 156 890 |
2018-06-27 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −914 | 128 305 | −0,71 | |||
2018-06-27 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −5 086 | 30 000 | −14,50 | |||
2018-06-27 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −6 000 | 52 541 | −10,25 | 9,26 | −55 552 | 486 456 |
2018-06-27 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 914 | 58 541 | 1,59 | 2,68 | 2 450 | 156 890 |
2018-06-27 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 5 086 | 57 627 | 9,68 | 2,36 | 12 003 | 136 000 |
2018-06-14 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | X | −12 000 | 35 086 | −25,49 | |||
2018-06-14 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −12 000 | 52 541 | −18,59 | 8,00 | −96 049 | 420 543 |
2018-06-14 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | X | 12 000 | 64 541 | 22,84 | 2,36 | 28 320 | 152 317 |
2018-03-05 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 225 000 | 225 000 | |||||
2018-03-05 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
A - Award | 30 000 | 52 541 | 133,09 | ||||
2017-11-09 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −6 388 | 31 526 | −16,85 | ||||
2017-11-09 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −6 153 | 0 | −100,00 | ||||
2017-11-09 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 6 388 | 22 541 | 39,55 | 2,36 | 15 076 | 53 197 | |
2017-11-09 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 6 153 | 16 153 | 61,53 | 0,80 | 4 922 | 12 922 | |
2017-10-20 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −10 000 | 129 219 | −7,18 | 2,68 | −26 800 | 346 307 | |
2017-10-20 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −10 000 | 10 000 | −50,00 | 9,60 | −96 000 | 96 000 |
2017-10-20 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 10 000 | 20 000 | 100,00 | 2,68 | 26 800 | 53 600 | |
2017-10-20 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −6 000 | 47 086 | −11,30 | 2,36 | −14 160 | 111 123 | |
2017-10-20 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −6 000 | 10 000 | −37,50 | 9,09 | −54 556 | 90 927 |
2017-10-20 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 6 000 | 16 000 | 60,00 | 2,36 | 14 160 | 37 760 | |
2017-09-27 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −6 000 | 53 086 | −10,15 | 2,36 | −14 160 | 125 283 | |
2017-09-27 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −6 000 | 10 000 | −37,50 | 8,44 | −50 624 | 84 373 |
2017-09-27 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 6 000 | 16 000 | 60,00 | 2,36 | 14 160 | 37 760 | |
2017-03-23 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
M - Exercise | −5 000 | 6 153 | −44,83 | ||||
2017-03-23 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −5 000 | 10 000 | −33,33 | 9,09 | −45 435 | 90 870 |
2017-03-23 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 5 000 | 15 000 | 50,00 | 0,80 | 4 000 | 12 000 | |
2017-03-06 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 310 000 | 310 000 | |||||
2016-06-03 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
P - Purchase | 2 500 | 10 000 | 33,33 | 5,32 | 13 288 | 53 152 | |
2016-06-03 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
P - Purchase | 2 500 | 7 500 | 50,00 | 5,48 | 13 693 | 41 080 | |
2016-06-01 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
P - Purchase | 2 500 | 5 000 | 100,00 | 5,46 | 13 642 | 27 284 | |
2016-06-01 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
P - Purchase | 2 500 | 2 500 | 5,46 | 13 644 | 13 644 | ||
2016-03-14 |
|
4 | VCYT |
VERACYTE, INC.
Stock option (right to buy) |
A - Award | 225 000 | 225 000 | |||||
2015-03-05 |
|
4 | VCYT |
VERACYTE, INC.
Stock Option (right to buy) |
A - Award | 225 000 | 225 000 | |||||
2014-06-30 |
|
4 | VCYT |
VERACYTE, INC.
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 97 000 | −1,02 | ||||
2014-06-30 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 17,95 | −17 950 | |
2014-06-30 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 1 000 | 1 000 | 2,36 | 2 360 | 2 360 | ||
2014-06-23 |
|
4 | VCYT |
VERACYTE, INC.
Employee Stock Option (right to buy) |
M - Exercise | −2 000 | 98 000 | −2,00 | ||||
2014-06-23 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −2 000 | 0 | −100,00 | 16,95 | −33 900 | |
2014-06-23 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 2 000 | 2 000 | 2,36 | 4 720 | 4 720 | ||
2014-06-23 |
|
4 | VCYT |
VERACYTE, INC.
Employee Stock Option (right to buy) |
M - Exercise | −2 000 | 11 153 | −15,21 | ||||
2014-06-23 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
S - Sale | X | −2 000 | 0 | −100,00 | 15,95 | −31 900 | |
2014-06-23 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
M - Exercise | 2 000 | 2 000 | 0,80 | 1 600 | 1 600 | ||
2014-06-23 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
J - Other | −125 000 | 0 | −100,00 | ||||
2014-06-23 |
|
4 | VCYT |
VERACYTE, INC.
Common Stock |
J - Other | −125 000 | 0 | −100,00 | ||||
2014-02-21 |
|
4 | VCYT |
VERACYTE, INC.
Stock option (right to buy) |
A - Award | 140 000 | 140 000 | |||||
2013-10-29 | 3 | VCYT |
VERACYTE, INC.
Common Stock |
125 000 | ||||||||
2013-10-29 | 3 | VCYT |
VERACYTE, INC.
Common Stock |
125 000 | ||||||||
2013-10-29 | 3 | VCYT |
VERACYTE, INC.
Common Stock |
99 085 |